Skip to content

Clinical trials

Phase 2 Anosmia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anosmia Phase: Phase 2 Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20191
20203
20214
20222
20234
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Active, not recruiting1
Not yet recruiting1
Recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Washington University School of Medicine6
Cyrano Therapeutics, Inc.1
Duke University1
Icahn School of Medicine at Mount Sinai1
Ivan FN Hung MD1
Massachusetts General Hospital1
Medical University of South Carolina1
Montreal Heart Institute1
Second Affiliated Hospital, Zhejiang University, School of Medicine1
Soad Ali1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anosmia16
COVID-199
Olfaction Disorders7
Post-Acute COVID-19 Syndrome2
Virus Diseases2
Abdominal Pain1
Ageusia1
Arthralgia1
Chest Pain1
Confusion1

Trials

Showing 26 to 16 of 16. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.